Colorectal Neoplasms

我们是谁

  • 1 月 10, 2024
    Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)
  • 1 月 9, 2024
    DETERMINE Trial Treatment Arm 2: Atezolizumab in Adult, Teenage/Young Adults and Paediatric Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
  • 1 月 8, 2024
    M9241 与肝动脉输注泵 (HAIP) 和全身疗法联合用于转移性结直肠癌或肝内胆管癌患者的治疗
  • 12 月 8, 2022
    Pembrolizumab and Disitamab Vedotin in HER2-expressing Metastatic Colorectal Cancer
  • 12 月 8, 2022
    Disitamab Vedotin Combined With Tislelizumab in Advanced HER2 Positive Colorectal Cancer
  • 7 月 26, 2022
    一项针对转移性结直肠癌晚期患者的 Nivolumab-relatlimab 固定剂量联合疗法对比瑞戈非尼或 TAS-102 的研究
  • 4 月 5, 2022
    用于治疗结直肠腹膜转移瘤的 PIPAC
  • 4 月 5, 2022
    A Study of a Personalized Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
  • 4 月 5, 2022
    Study of Lenvatinib (MK-7902/E7080) in Combination With Pembrolizumab (MK-3475) Versus Standard of Care in Participants With Metastatic Colorectal Cancer (MK-7902-017/E7080-G000-325/LEAP-017)
  • 4 月 5, 2022
    抗程序性死亡配体-1 Durvalumab抗体（MEDI4736）与奥拉帕利（Olaparib）和/或塞地拉尼（Cediranib）联合治疗晚期实体瘤和晚期或复发性卵巢癌、三阴性乳腺癌、肺癌、前列腺癌和结直肠癌的I/II期研究...

发现舞蹈艺术

发现舞蹈艺术

无论您喜欢芭蕾、爵士还是街舞，我们都有适合您的课程。